Edition:
United Kingdom

Income Statements: bluebird bio Inc (BLUE.OQ)

BLUE.OQ on NASDAQ Stock Exchange Global Select Market

135.75USD
15 Jul 2019
Change (% chg)

$3.10 (+2.34%)
Prev Close
$132.65
Open
$133.27
Day's High
$137.55
Day's Low
$132.74
Volume
126,082
Avg. Vol
182,764
52-wk High
$181.70
52-wk Low
$87.64

Interim Income Statement
View: AnnualInterim

In Millions ofU.S. Dollars
(except for per share items)
2019
2019-03-31
Period Length
3 Months
Revenue 12.5
Other Revenue, Total --
Total Revenue 12.5
Cost of Revenue, Total --
Gross Profit --
Selling/General/Admin. Expenses, Total 60.3
Research & Development 123.1
Depreciation/Amortization --
Interest Expense, Net - Operating --
Interest/Investment Income - Operating --
Interest Expense(Income) - Net Operating --
Unusual Expense (Income) --
Other Operating Expenses, Total 0.3
Total Operating Expense 183.6
Operating Income (171.2)
Interest Expense, Net Non-Operating --
Interest/Invest Income - Non-Operating --
Interest Income(Exp), Net Non-Operating 10.1
Gain (Loss) on Sale of Assets --
Other, Net (3.4)
Net Income Before Taxes (164.5)
Provision for Income Taxes (0.0)
Net Income After Taxes (164.4)
Minority Interest --
Equity In Affiliates --
U.S. GAAP Adjustment --
Net Income Before Extra. Items (164.4)
Accounting Change --
Discontinued Operations --
Extraordinary Item --
Tax on Extraordinary Items --
Net Income (164.4)
Preferred Dividends --
General Partners' Distributions --
Miscellaneous Earnings Adjustment --
Pro Forma Adjustment --
Interest Adjustment - Primary EPS --
Income Available to Com Excl ExtraOrd (164.4)
Income Available to Com Incl ExtraOrd (164.4)
Basic Weighted Average Shares 54.96
Basic EPS Excluding Extraordinary Items (2.992)
Basic EPS Including Extraordinary Items (2.992)
Dilution Adjustment --
Diluted Weighted Average Shares 54.96
Diluted EPS Excluding ExtraOrd Items (2.992)
Diluted EPS Including ExtraOrd Items (2.992)
DPS - Common Stock Primary Issue 0.000
Gross Dividends - Common Stock 0.0
Total Special Items --
Normalized Income Before Taxes (164.5)
Effect of Special Items on Income Taxes --
Inc Tax Ex Impact of Sp Items (0.0)
Normalized Income After Taxes (164.4)
Normalized Inc. Avail to Com. (164.4)
Basic Normalized EPS (2.992)
Diluted Normalized EPS (2.992)

UPDATE 1-Bluebird prices gene therapy at 1.58 mln euros over 5 years

June 14 Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe this month to treat a rare genetic blood disorder. The company proposed an installment plan, with 315,000 euros paid up front and four additional annual payments due only if the treatment continues to be effective.